documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
20 rows where docket_id = "FDA-2017-P-5787" and posted_year = 2020 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-P-5787-0231 | FDA | None FDA-2017-P-5787 | Melcangi_Methylation of SRD5A2 in CSF of PFS Pts (Endocr Connect 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:07:15Z | 0 | 0 | 0900006484984797 | |||
| FDA-2017-P-5787-0222 | FDA | None FDA-2017-P-5787 | CMDh Recommendation re Anxiety in Propecia SPC_EMA (Apr 2018) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:27:24Z | 0 | 0 | 0900006484984768 | |||
| FDA-2017-P-5787-0223 | FDA | None FDA-2017-P-5787 | Diviccaro_Finasteride, Hippocampal Neurogenesis and Neuroinflammation in Rats (Psychneuroendocrin 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:28:17Z | 0 | 0 | 0900006484984769 | |||
| FDA-2017-P-5787-0230 | FDA | None FDA-2017-P-5787 | Levine_Court let Merck hide secrets (Reuters 9-11-19) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:06:26Z | 0 | 0 | 0900006484984796 | |||
| FDA-2017-P-5787-0232 | FDA | None FDA-2017-P-5787 | Nguyen and Trinh_Suicidality and Psychological AEs w Finasteride (JAMA Derm 2020) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:09:31Z | 0 | 0 | 0900006484984798 | |||
| FDA-2017-P-5787-0241 | FDA | None FDA-2017-P-5787 | Summary of Product Characteristics_ANSM_English (Dec 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:34:25Z | 0 | 0 | 090000648498449a | |||
| FDA-2017-P-5787-0224 | FDA | None FDA-2017-P-5787 | Gulbinovic_Final Assessment Report of PSUR (Sweden MPA 2007) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:29:58Z | 0 | 0 | 0900006484984791 | |||
| FDA-2017-P-5787-0235 | FDA | None FDA-2017-P-5787 | Petition Supplement 2 Post-Finasteride Syndrome Foundation | Notice | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T17:17:17Z | 0 | 0 | 0900006484984494 | |||
| FDA-2017-P-5787-0226 | FDA | None FDA-2017-P-5787 | Kaufman_Finasteride Rx for AGA (J Am Acad Dermatol 1998) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:31:57Z | 0 | 0 | 0900006484984793 | |||
| FDA-2017-P-5787-0228 | FDA | None FDA-2017-P-5787 | Khera and Mirabel_Penile Vascular Abnormalities in PFS (Translat Androl Urol 2020) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:46:53Z | 0 | 0 | 0900006484984794 | |||
| FDA-2017-P-5787-0236 | FDA | None FDA-2017-P-5787 | Propecia Proposed Prescribing Info_Revision Marks (2002) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:27:53Z | 0 | 0 | 0900006484984495 | |||
| FDA-2017-P-5787-0238 | FDA | None FDA-2017-P-5787 | Propecia Summary of Product Characteristics_MHRA UK (Jun 2018) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:29:49Z | 0 | 0 | 0900006484984497 | |||
| FDA-2017-P-5787-0240 | FDA | None FDA-2017-P-5787 | Reminder of Risk of Psychiatric and Sexual Disorders_ANSM webpage (Feb 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:33:26Z | 0 | 0 | 0900006484984499 | |||
| FDA-2017-P-5787-0237 | FDA | None FDA-2017-P-5787 | Propecia Summary of Product Characteristics_ANSM France (Dec 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:28:52Z | 0 | 0 | 0900006484984496 | |||
| FDA-2017-P-5787-0225 | FDA | None FDA-2017-P-5787 | Irwig_Finasteride and Suicide Case Series (Dermatol 2020) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:30:45Z | 0 | 0 | 0900006484984792 | |||
| FDA-2017-P-5787-0229 | FDA | None FDA-2017-P-5787 | Letter to Health Professionals_Reminder of Risk of Psychiatric and Sexual Disorders_ANSM France (Feb 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:52:35Z | 0 | 0 | 0900006484984795 | |||
| FDA-2017-P-5787-0227 | FDA | None FDA-2017-P-5787 | Godar and Bortolato_Finasteride Reduces Response to Stressful and Rewarding Stimuli (Biomolec 2019) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T15:41:44Z | 0 | 0 | 0900006484984790 | |||
| FDA-2017-P-5787-0233 | FDA | None FDA-2017-P-5787 | Periodic Safety Update Report _19_Merck (Nov 2006) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:24:23Z | 0 | 0 | 0900006484984799 | |||
| FDA-2017-P-5787-0234 | FDA | None FDA-2017-P-5787 | Petition Supplement 1 Post-Finasteride Syndrome Foundation | Notice | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T17:16:41Z | 0 | 0 | 0900006484984493 | |||
| FDA-2017-P-5787-0239 | FDA | None FDA-2017-P-5787 | Red Hand Letter re Finasteride_BfArM Germany (Jul 2018) | Supporting & Related Material | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T16:30:50Z | 0 | 0 | 0900006484984498 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;